sometimes increases in HDL Liver : Improvements in fatty liver disease (reduced liver fat, improved liver enzymes) Cardiovascular Improvements : Blood Pressure : Significant reductions in systolic and diastolic blood pressure Cardiovascular Events : According to SELECT trial (semaglutide), 20% reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) Heart Function : Improvements in cardiac structure and function markers Physical Function Improvements : Mobility : Improved ability to walk, climb stairs, engage in physical activities Joint Pain : Reduced knee, hip, and back pain from decreased weight-bearing stress Sleep : Improvements in sleep quality
This included circumvention of the complex downhill syndrome, as well as a sudden decrease of blood supply, decreased NO levels in the inferior caval vein tissue, an immediate heavy loss of endothelial cells from the vascular wall, a lower eNOS production ability (Rangan and Bulkley, 1993
Cycle Length Factors: Short Cycles: 4 weeks Suitable for first research, acute effects Standard Cycles: 6 weeks Most common in research protocols Extended Cycles: 8 weeks For long-term adaptation studies Factors: Longer cycles may need more intensive tracking Off-Cycle Periods: Minimum Duration: Equal to cycle length Standard Protocol: 4-8 weeks off between cycles Purpose: Allow receptor response restoration, assess sustained effects Tracking: Continue assessment during off-cycle period Combination Protocols Research often studies IGF1 LR3 in mix with other compounds to examine combined effects or multiple pathways
All of our Vitamins are made in the USA in an FDA-registered facility that follows Good Manufacturing Practices, which is the highest standard achievable
doi: 10.1089/omi.2011.0118
